C12N 2710/16062
By genetic engineering
Official title: by genetic engineering
C12N2710/16062 (By genetic engineering) appears on 14 US grants and 21 published applications in this corpus.
Search patents in C12N- Granted patents
- 14
- Published applications
- 21
- Assignees
- 17
- Inventors
- 32
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 3 |
| 2005 | 1 | 0 |
| 2006 | 2 | 1 |
| 2007 | 1 | 0 |
| 2008 | 1 | 2 |
| 2009 | 1 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 2 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 2 |
| 2018 | 1 | 0 |
| 2019 | 0 | 2 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 2 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for the treatment of skin diseases16 Jun 2026US 12,655,447 B2Krystal Biotech, Inc.
- Vaccines for treating SARS infections in cancer patients6 Jan 2026US 12,516,296 B2City of Hope
- EHV with inactivated UL18 and/or UL812 Jul 2022US 11,384,365 B2
- Compositions and methods for generating reversion free attenuated and/or replication incompetent vaccine vectors19 Oct 2021US 11,149,255 B2BioVentures, LLC
- Koi herpesvirus vaccine3 Apr 2018US 9,931,396 B2Gesval S.A.
- Modified Herpes Simplex Virus Type 16 Nov 2025US 2025/0340903 A1Eg 427
- Vaccines for treating sars infections in cancer patients27 Oct 2022US 2022/0340884 A1City of Hope
- Compositions and methods for the treatment of skin diseases23 Dec 2021US 2021/0395775 A1Krystal Biotech, Inc.
- Ehv with inactivated ul18 and/or ul819 Sep 2019US 2019/0284577 A1Boehringer Ingelheim Vetmedica GmbH
- Compositions and methods for generating reversion free attenuated and/or replication incompetent vaccine vectors11 Jul 2019US 2019/0211313 A1BioVentures, LLC
Most cited
By later US patents
- Recombinant infectious laryngotracheitis virus and uses thereof7US 6,875,856 B2Syntro Corporation · 2005
- Composition and method for treating cancer using herpes virus7US 7,264,814 B2M's Science Corporation · 2007
- Recombinant infectious laryngotracheitis virus and uses thereof6US 7,364,893 B2Schering-Plough Animal Health Corporation · 2008
- Recombinant infectious laryngotracheitis virus and uses thereof5US 7,892,564 B2Schering-Plough Animal Health Corporation · 2011